Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain
Active, not recruitingNCT05763758
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to identify spatiotemporal alterations in thalamocortical circuitry functioning in both healthy subjects and patients with chronic pain, combining multimodal neuroimaging.
Study details
- Official title
- Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain
- Conditions
- Experimental Pain
- Low Back Pain
- Interventions
- Sponsor
- Massachusetts General Hospital
- Collaborators
- Florida State University
- Start date
- 2023-11-21
- Primary completion
- 2024-12-20
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Healthy subjects for both MGH and FSU sites Inclusion Criteria: 1. healthy male and female adults 2. Between the ages of 18 and 60 years 3. Meeting the MRI / MEG / EEG screening criteria 4. Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen. Exclusion Criteria: 1. Current or past history of major medical, neurological, or psychiatric illness based on self-report 2. History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia) 3. History of head trauma 4. Pregnant or lactating 5. Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner) 6. Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1) 7. Active substance abuse disorders (based on subject self-report) Subjects with chronic low back pain (MGH site) Inclusion Criteria: 1. Volunteers 18-60 years of age 2. Meet the Classification Criteria of the chronic LBP (having low back pain for more than 6 months) 3. At least 4/10 clinical pain on the 0-10 LBP NRS 4. Meeting the MRI / MEG / EEG screening criteria 5. Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen. Exclusion Criteria: 1. Specific causes of back pain (eg, cancer, fractures, spinal stenosis, infections) 2. Complicated back problems (eg, prior back surgery, medicolegal issues) 3. The intent to undergo surgery during the time of involvement in the study 4. Current or past history of major medical, neurological, or psychiatric illness based on self-report 5. History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia) 6. History of head trauma 7. Pregnant or lactating 8. Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner) 9…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05763758